Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform (Q42606268)
Jump to navigation
Jump to search
scientific article published on July 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform |
scientific article published on July 1999 |
Statements
1 reference
Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform (English)
1 reference
1 reference
Wessel I
1 reference
Jensen LH
1 reference
Jensen PB
1 reference
Falck J
1 reference
Rose A
1 reference
Roerth M
1 reference
Sehested M
1 reference
1 July 1999
1 reference
1 reference